Clinical trials
Placebo clinical trials
Below are recruiting placebo clinical trials, each written for real people, not researchers. We’re tracking 5,184 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07654114RecruitingPhase 2
Testing CTH120 for men with Fragile X syndrome
This trial tests a new medicine called CTH120 to see if it is safe and helpful for adult men with Fragile X syndrome. You may be able to join if you meet certain health and age requirements.
Barcelona, BarcelonaAges 18–45 - NCT07654140RecruitingPhase 2
Testing a new drug for uncontrolled high blood pressure
This trial tests a new drug called SAL0140 for people whose high blood pressure is not controlled by current treatments. It may help lower blood pressure when other medications haven't worked well enough.
Beijing, Beijing MunicipalityAges 18–75 - NCT07654413RecruitingPhase 4
Tamsulosin with or without tadalafil for catheter removal after urinary retention
This trial tests whether adding tadalafil to tamsulosin helps men pass a catheter removal test after a first-time urinary blockage caused by an enlarged prostate. The goal is to find which treatment works best to avoid needing a catheter again.
Banī Suwayf, Beni Suweif GovernorateAges 50 years+ - NCT07654777Recruiting
Vitamin D for better performance in healthy adults
This study tests if taking vitamin D supplements can help young, healthy adults stay sharp and perform well under stress. You may be eligible if your current vitamin D level is low but not severely low.
Silver Spring, MarylandAges 18–40 - NCT07655180RecruitingPhase 3
Testing a new COVID-19 vaccine with or without another vaccine
This trial tests a new COVID-19 vaccine called VYD2311, alone or with another COVID-19 vaccine, in healthy adults. The goal is to see if it is safe and helps your body fight the virus.
Overland Park, KansasAges 18–49 - NCT07656350Recruiting
Cannabis-like drug and sleep loss study for anxiety
This study tests whether a cannabis-like drug can help people with higher-than-normal anxiety cope with a night of very little sleep. You will be asked to sleep only 4 hours on one occasion.
London, LondonAges 18–60 - NCT07656688RecruitingPhase 2
Finding the best dose for a dry eye treatment
This trial tests different doses of a new eye drop (HUC1-394) to see which dose works best for people with moderate to severe dry eye disease. You may qualify if your dry eye symptoms have lasted at least 3 months and you have low tear production along with other signs of dry eye.
SeoulAges 19 years+ - NCT07656727RecruitingPhase 2
A study of BGE-102 for obesity and heart risk
This trial tests an experimental drug called BGE-102 in people with obesity and signs of inflammation. It aims to see if the drug can help reduce body weight and improve heart health. Participants must be willing to keep a stable diet and exercise routine.
Chandler, ArizonaAges 18 years+ - NCT07657793RecruitingPhase 2/Phase 3
Sirolimus for Lupus-Related Low Platelets
This trial tests sirolimus, an immune-system-calming medicine, for people with lupus who also have very low platelet counts (ITP). It may help reduce bleeding risk and improve platelet numbers.
Beijing, Beijing MunicipalityAges 18–65 - NCT07658274Recruiting
Nerve stimulation during sleep to boost memory
This trial tests if mild electrical nerve stimulation during sleep can help strengthen memory. It is for healthy young adults who are right-handed and have good sleep quality.
Xi'an, ShaanxiAges 18–35 - NCT07658534RecruitingPhase 2/Phase 3
Ziresovir for high-risk adults with RSV
This trial tests an antiviral drug called Ziresovir in adults with RSV who have health conditions that make them high-risk, such as lung disease, heart disease, or a weakened immune system. It aims to see if the drug can reduce symptoms like coughing and shortness of breath.
Beijing, Beijing MunicipalityAges 18–85 - NCT07660614RecruitingPhase 1/Phase 2
Testing a new drug for people with ALS
This trial studies an experimental drug called LTX-002 for people with ALS. It aims to see if the drug is safe and can slow down the disease.
LübeckAges 18–75 - NCT07662330Recruiting
Spermidine for weight and cholesterol in overweight adults
This trial tests if a natural supplement called spermidine can help lower cholesterol and body weight in overweight people with high cholesterol. You cannot be on any cholesterol or diabetes medications.
Shanghai, Shanghai MunicipalityAges 18–60 - NCT07665658Recruiting
Supplements for ADHD: Calming brain inflammation in kids
This study tests whether special supplements can help calm inflammation in the brain and improve ADHD symptoms in children. It might be a good fit if your child's ADHD is diagnosed and they are not taking antibiotics or have other health issues like gut problems or severe allergies.
Peshawar, KPKAges 6–12 - NCT07666022RecruitingPhase 1
Safety study of MF1 for Parkinson's-related constipation
This early-phase study tests a new treatment called MF1 for Parkinson's-related symptoms, especially constipation. It first checks safety in healthy volunteers, then in people with Parkinson's who have slow bowel movements.
Sumida-ku, TokyoAges 18–85 - NCT07666178RecruitingPhase 3
Continuous ESP Block for Pain After Bypass Surgery
This study tests a continuous nerve block (ESP block) placed near the spine to control pain after bypass surgery. It aims to see if this block improves recovery and reduces pain.
São Paulo, São PauloAges Any age - NCT07666685Recruiting
Beetroot Extract for Health in Adults 75+
This study looks at whether taking beetroot extract can help improve quality of life and daily function in adults 75 and older. You will be asked to take the extract and complete simple health questionnaires.
Pamplona, NavarreAges 75 years+ - NCT07668856RecruitingPhase 3
CBD for children with hard-to-treat epilepsy
This trial tests if adding cannabidiol (CBD) to your child's current seizure medicines can reduce seizures. It uses a personalized approach to see if CBD works for each child.
Utrecht, UtrechtAges 1–18 - NCT07669467RecruitingPhase 3
Nuvastatic for fatigue in triple-negative breast cancer patients
This trial tests whether Nuvastatic, a natural supplement, can help reduce fatigue in women with triple-negative breast cancer who are about to start chemotherapy. If you have stable or worsening fatigue and meet the other criteria, you may be able to join.
Visakhapatnam, Andhra PradeshAges 18–65 - NCT07669519RecruitingPhase 3
Supplement for fatigue in stage IV colon cancer
This study tests an oral supplement (Nuvastatic) to see if it helps reduce fatigue in people with stage IV colon cancer who are starting chemotherapy for the first time. If you are 18–65 and have fatigue that is affecting you, this trial might offer a way to feel better.
Srikakulam, Andhra PradeshAges 18–65 - NCT07669584RecruitingPhase 2/Phase 3
Testing PKB171 for mild male infertility in couples
This study tests a new oral medication (PKB171) compared to a placebo for couples who have mild male infertility and have not tried IVF/ICSI before. The goal is to see if PKB171 can help them conceive naturally.
Pamplona, NavarreAges 18–38 - NCT07639268Enrolling by invitation
Support program for advanced cancer patients and their caregivers
This study tests a support program designed to help advanced cancer patients (stage III or IV) and their caregivers manage stress and emotional distress together. The program aims to improve coping and quality of life for both the patient and the person caring for them.
Ponce, PRAges 21–105 - NCT07634133Enrolling by invitation
Omega-3 fatty acids and red blood cell health in active men
This study tests whether omega-3 supplements (healthy fats found in fish) change the structure of your red blood cells in ways that might improve how your body works. You'll take supplements for several weeks while researchers measure changes in your blood.
KatowiceAges 18–60 - NCT07619924Enrolling by invitationEarly Phase 1
Phage Cocktail for Hard-to-Treat Skin Infections
This study tests a new treatment called a phage cocktail (viruses that kill bacteria) for skin infections caused by bacteria that don't respond well to regular antibiotics. The treatment is applied directly to the wound to see if it's safe and effective.
Xi'an, ShaanxiAges 18–75
Hear when a new Placebo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo?
- Yes. Clin2 currently lists 5,184 recruiting placebo studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.